Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PRECIGEN, INC. (PGEN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PRECIGEN, INC. (PGEN), most recent 12 months reported: revenue $9.68M, net loss $157.71M, free cash flow -$115.22M. Latest balance sheet on file: liquid cash $38.21M, total debt $93.88M, net cash -$55.67M. From SEC filings. Others in Pharmaceutical Preparations: BIOAGE LABS, INC. · Evommune, Inc. · Zenas BioPharma, Inc. · Opus Genetics, Inc. · INTERNATIONAL STEM CELL CORPORATION · Aclaris Therapeutics, Inc. · Coya Therapeutics, Inc. · Adagene Inc.

Stock screener

Watchlist